P158 REMOTE FOLLOW–UP OF ISCHEMIC HEART DISEASE AFTER MYOCARDIAL INFARCTION: PRELIMINARY RESULTS OF A TELEVISIT PROJECT IN THE CARDIOLOGY OF G.B. GRASSI HOSPITAL IN ROME
Autor: | G Pastena, M Bocchino, L Paraggio, F Ferranti, R Scardala, C Sorrentino, M Romano, F Ammirati |
---|---|
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | European Heart Journal Supplements. 25:D101-D102 |
ISSN: | 1554-2815 1520-765X |
Popis: | Introduction In literature there are few studies reported on follow–up of post infarction using telemedicine. Objective and Methods Considering recent pandemic and thanks to the development of digital also in its regulations, it was decided to organize a televisit service with a dedicated team (cardiologist, nurse, cardiology technician) for patients (pt) discharged after a myocardial infarction. The platform of Regione Lazio SISMED has been used to carry out all the necessary procedures (dematerialised recipe, booking, videoconference, digital signature reporting and sending to FSE). We selected pt with: ST elevation myocardial infarction (STEMI), myocardial infarction with no obstructive coronary atherosclerosis (MINOCA) or Takotsubo syndrome, non ST elevation myocardial infarction (NSTEMI) with high–risk, providing a follow–up to 1 and 4 months to monitor cardiovascular events, adherence to therapy, achievement of therapeutic targets and level of satisfaction. An Access file was designed for reporting and data collection. Results From 23–11–21 to 2–11–22, we followed 58 pt (average age 64±10 years, 73% males). Figure 1 represents the cardiovascular risk factors and Figure 2 the type and location of the myocardial infarction; at discharge (average stay 7±2 days), the ejection fraction of the left ventricle was 53±9%. At the televisit control at 1 month, 5 pt reported symptoms (4 dyspnea, 1 cardiopalm), all continued the antiaggregant therapy; Figure 3 shows those who have reached the target for LDL cholesterol (average 56±34 mg/dl), blood pressure (average 124±10 mmhg) and blood sugar level (average 107±19 mg/dl); 6 pt had no target LDL cholesterol (three stopped hypolipidaemic therapy). One pt showed intense pallor, asthenia and reduced hemoglobin (6 g/dl): after hospitalization, we found colon diverticulosis with bleeding (he took oral anticoagulant due to prior atrial fibrillation, suspended, with benefit). The 4–month follow–up was performed for 42 pt, with overlapping results, without reospedalizations. No pt died. Conclusions The televisit showed itself safe as an option in the follow–up of these pt, with a high approval rating. This was possible through the structuring of a health coordination center with a dedicated team, which also supported pt in the new path. |
Databáze: | OpenAIRE |
Externí odkaz: |